Cambridge: Exosome Diagnostics, Inc. has entered into an agreement with Amgen to evaluate the potential to advance drug development with Exosome’s proprietary liquid biopsy diagnostics technology and platform. ...
TORONTO, ONTARIO: - Clinical data demonstrates a positive benefit for patients in septic shock - Significant improvement in cardiovascular function was observed - Mortality benefit in the pre specified per protocol pat ...
PARSIPPANY, NJ: Laboratory Testing Data From More Than 19 Tropical and Developing Countries Provides Unique Insight Into Potential for Outbreak and Resistance Tracking Using Molecular Diagnostics
...
Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.